IMPEDIMED LIMITED — Director's Dealing 2024

Oct 20, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: ImpediMed Limited ABN: 089 705 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr McGregor Grant
Date of last notice	29 September 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest	Tortoise & Hare Superannuation Fund Pty
(including registered holder)	Ltd
Note: Provide details of the circumstances
giving rise to the relevant interest.	Mr Grant is a director of Tortoise & Hare
	Superannuation Fund Pty Ltd
	and a beneficiary of the superannuation fund.
Date of change	16 October 2024
No. of securities held prior to change	Indirect
	2,055,000 Ordinary shares
Class	1. Performance Rights
	2. Options
Number acquired	1. 6,500,000 Performance Rights
	2. 6,500,000 Options
Number disposed	Nil

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration	Nil
Note: If consideration is non-cash, provide
details and estimated valuation
No. of securities held after change	Indirect
	2,055,000 Ordinary shares
	Direct
	6,500,000 Performance Rights
	6,500,000 Options
Nature of change	Grant of performance rights and options
Example: on-market trade, off-market trade,	following shareholder approval at the
exercise of options, issue of securities under	general meeting held on 28 August 2024.
dividend reinvestment plan, participation in
buy-back

Part 2 – Change of director’s interests in contracts

Not applicable.

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No	No	No
If so, was prior written clearance	provided to allow the
trade to proceed during this period	?
If prior written clearance was provi	ded, on what date was
this provided?
ate of Notice: 21 October 2024

Date of Notice: 21 October 2024

• See chapter 19 for defined terms.

Appendix 3Y Page 2